Citing its “increased” commitment to fighting the coronavirus outbreak, Meridian Bioscience (VIVO -3.6%) announces that
it will provide no-cost samples of its proprietary technologies to
developers and manufacturers of molecular tests for COVID-19.
Specifically, it will provide its specialized
enzyme formulations (Fast RT-qPCR Mix and Lyo-Ready 1-Step RT-qPCR Mix)
for use in initial testing and evaluation in order to accelerate assay
development.
https://seekingalpha.com/news/3552131-meridian-bio-offers-help-to-coronavirus-test-makers
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.